Trials / Unknown
UnknownNCT02277808
Which Apparatus for Inhaled Pentamidine?
Which Apparatus for Inhaled Pentamidine? A Comparison of Drug Delivery to the Lung Between Two Nebulizers: The Respirgard II and the Isoneb.
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The reference nebulizer used for pentamidine nebulization is currently the Respirgard II ®, disposable pneumatic nebulizer. Other nebulizers are on the market and appear to have comparable properties and better availability to the hospital. Several studies remark that all nebulizers with comparable properties could be used for the nebulization.The aim of our work will be to evaluate and compare the pulmonary deposition between the reference nebulizer Respirgard II ®, and one of these nebulizers available on the market, the Isoneb ®. We will measure and compare these data's for each of the nebulizers via nebulization Amikacine and urinary dosage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 500mg Amikacine (Amukin®) diluted in 4mL NaCl (0,9%) | |
| DEVICE | Respirgard II | |
| DEVICE | Isoneb® |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-10-01
- First posted
- 2014-10-29
- Last updated
- 2014-10-29
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02277808. Inclusion in this directory is not an endorsement.